Increased Expression of Eotaxin in Bronchoalveolar Lavage and Airways of Asthmatics Contributes to the Chemotaxis of Eosinophils to the Site of Inflammation

Journal of Immunology

Volumn 159, Issue 9, 1997, Pages 4593-4601

  Lamkhioued, Bouchaib ^a,b   Renzi, Paolo M ^a,b   Abi Younes, Sylvie ^c   Garcia Zepada, Eduardo A ^c   Allakhverdi, Z ^b   Ghaffar, Omar ^a   Rothenberg, Marc D ^d   Luster, Andrew D ^c   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CYTOKINE; EOTAXIN;

ADULT; ARTICLE; ASTHMA; BIOSYNTHESIS; CHEMOTAXIS; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG LAVAGE; MALE; MIDDLE AGED; PATHOLOGY; RESPIRATORY SYSTEM;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE; CHEMOKINES, CC; CHEMOTAXIS; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RESPIRATORY SYSTEM;

EID: 0031279987     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Garcia-Zepada, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celstin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
2. Griffiths-Johnson, D. A., P. D. Collins, A. G. Rossi, P. J. Jose, and T. J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197:1167.
3. Jose, P. G., D. A Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
4. Ponath, P. D., S. Quin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. A. Gonzalo, W. Newman, J. C. Gutierrez-Ramos, and C. R. Mackay. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604.
5. Rothenberg, M. E., A. D Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin-4 induced tumor suppression. Proc. Natl. Acad. Sci. USA 92:8960.
6. Ganzalo, J. A., G. Q. Jia, V. Aguirre, D. Friend, A. J. Coyle, N. A. Jenkins, G. S. Lin, H. Katz, A. Lichtman, N. Copeland, M. Kopf, and J. C. Gutierrez-Ramos. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but is not restricted to a Th2-type response. Immunity 4:1.
7. Rothenberg, M. E., A. D. Luster, C. M. Lilly, J. M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211.
8. Butterfield, J. H., and K. M. Leiferman. 1993. Immunology of Eosinophils. H. Smith and R. M. Cook, eds. Academic Press, New York, pp. 152-192.
9. Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. Beasley, O. P. Twentyman, R. H. Howarth, and S. T. Holgate. 1993. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434.
10. Smith, H. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. 1992. Clin. Exp. Allergy 22:187.
11. Seminario, M. C., and G. J. Gleich. 1994. The role of eosinophils in the pathogenesis of asthma. Curr. Opin. Immunol. 6:860.
12. Alam, R., S. Stafford, P. Forsythe, R. Harrison, D. Faubion, M. A. Lett-Brown, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150:3442.
13. Dahinden C. A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil and eosinophil-activating chemokine. J. Exp. Med. 179:751.
14. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S. H. Lima, Y. Li, B. Kreider, G. Garotta, M. Thelen, and M. Baggiolini. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379.
15. Garcia-Zepada, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CKR)-2 and -3. J. Immunol. 157:5613.
16. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541.
17. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
18. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
19. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin-5. J. Exp. Med. 172:1425.
20. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, and Y. Kanai. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and auto-antibody production. J. Exp. Med. 173:429.
21. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225.
22. Leung, D. Y. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin-4, interleukin-5, and interferon-γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33.
23. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepada, M. E. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767.
24. Hamid, Q. 1997. Immunocytochemistry. In Allergy and Allergic Diseases, Vol. 2. A. B. Kay, ed. Blackwell Science Ltd., London, U.K., p. 780.
25. Hamid, Q., J. Barkans, D. S. Robinson, S. R. Durham, and A. B. Kay. 1992. Coexpression of CD25 and CD3 in atopic allergy and asthma. Immunology 75: 659.
26. Cubitt, C. L., R. N. Lausch, and J. E. Oakes. 1994. Differential regulation of granulocyte-macrophage factor gene expression in human corneal cells by proinflammatory cytokines. J. Immunol. 153:232.
27. Van Damme, J., P. Proost, J. P. Lenaerts, and G. Opdenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Immunol. 176:59.
28. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110.
29. Lukacs, N. W., R. M. Streiter, C. L. Shaklee, S. W. Chensue, and S. L. Kunkel. 1995. Macrophage inflammatory protein-1 α influences eosinophil recruitment in antigen-specific airway inflammation. Eur. J. Immunol. 25:245.
30. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and R. P. Schleimer. 1995. Expression of the chemokine RANTES by human bronchial epithelial cell line: modulation by cytokines and glycocorticoids. J. Immunol. 155:410.
31. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines: effect of the chemokine RANTES. J. Immunol. 153:2153.
32. Kapp, A., G. Zeck Kapp, W. Czech, and E. Schopf. 1994. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J. Invest. Dermatol. 102:906.
33. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Y. Viksman, and A. P. Kaplan. 1992. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 149:636.
34. Bischoff, S. C., M. Kreiger, T. Brunner, and C. A. Dahinden. 1992. Monocyte chemotactic protein 1 is potent activator of human basophils. J. Exp. Med. 175: 1271.
35. Alam, R., M. A. Lett-Brown, P. A. Forsythe, D. J. Anderson-Walters, C. Kenamore, C. Kormos, and J. A. Grant. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723.
36. Alam, R., P. A. Forsythe, S. Stafford, M. A. Lett-Brown, and J. A. Grant. 1992. Macrophage inflammatory protein-1α activates basophils and mast cells. J. Exp. Med. 176:781.
37. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for Th2 (interleukin-4 and interleukin-5) and Th1 (interleukin-2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477.
38. Minshall, E. M., L. Cameron, F. Lavigne, D. Y. M. Leung, D. Hamilos, E. A. Garcia-Zepada, M. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am. J. Respir. Cell Mol. Biol. In press.
39. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1. RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1398.
40. Alam, R., J. York, and M. Boyars. 1994. The involvement of the chemokines in bronchial asthma: the detection of the mRNA for MCP-1, MCP-3, RANTES, MIP-1α and IL-8 in bronchoalveolar lavage cells, and the measurement of RANTES and MIP-1α in the lavage fluid. J. Allergy Clin. Immunol. 93:183. (Abstr.).
41. Rothenberg, M. E., J. A. MacLean, E. Pearlmen, A. D. Luster, and P. Leder. 1997. Targeted distruption of chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785.
42. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35.
43. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. Hamid. 1992. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390.
44. Yamagushi, Y., T. Suda, J. Suda, M. Egushi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin-5 supports the terminal differential and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43.
45. Lopez, A. F., C. J. Sanderson, G. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219.
46. Schweizer, R. C., B. A. Welmers, J. A. Raaijmakers, P. Zanen, J. W. Lammers, and L. Koenderman. 1994. RANTES and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83:3697.
47. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice. Mol. Med. 2:334.